BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 19, 2016
View Archived Issues
Biallelic mutations in REV7 gene are associated with Fanconi anemia
Read More
Galecto Biotech patents galectin 3 ligands
Read More
Novel AR antagonists show promising activity in castration resistant prostate cancer
Read More
Akers Biosciences presents results for OxiCheck disposable breath test
Read More
Auris Medical's phase III trial of Keylizen does not meet its two coprimary efficacy endpoints
Read More
Xenetic Biosciences starts collaboration with Excivion to develop Zika vaccine
Read More
Hybrid CB1/iNOS antagonist ameliorates liver fibrosis in preclinical models
Read More
Insys Therapeutics enrolls first patient in phase II trial of canabidiol
Read More
Ambrx's IND for ARX-788 becomes active
Read More
Aclaris Therapeutics reports data from WART-201 phase II trial
Read More
NIH grants support work at Feinstein Institute on bioelectronic medicine and sepsis
Read More
Mayne Pharma acquires dermatology-related assets from GlaxoSmithKline
Read More
NIAID funding supports testing of Kineta's broad-spectrum antivirals in preclinical Zika models
Read More
Intellia presents preclinical data on in vivo gene editing with LNPs to deliver CRISPR/Cas9
Read More
Kancera describes ROR1 inhibitors
Read More
Bayer Healthcare develops sGC activators
Read More
Experimental inhibition of S100P gene reverses trastuzumab resistance in breast cancer
Read More
Kadimastem signs agreement with unnamed medical device company for diabetes-related device
Read More
Physiomics signs share purchase agreement with BioMoti
Read More
Chinese clinical trial authorization for TaiGen's furaprevir
Read More
Michael James Enterprises begins research on new dronabinol-based formulation for anorexia nervosa
Read More
Juniper Pharmaceuticals completes phase IIb trial of COL-1077
Read More